Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Transdermal Estrogen in Turner Syndrome
NCT06544473Phase 4Recruiting
- Sponsor
- Aarhus University Hospital
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol in Turner syndrome (TS) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Equipotency of Estradiol Regimens at 14 days. Started Nov 2021; status: recruiting.
02
Drugs
estradiol
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT06544473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06544473.